Phase II trial of cisplatin as second-line chemotherapy in patients with advanced or recurrent endometrial carcinoma A Gynecologic Oncology Group study

1984 ◽  
Vol 7 (3) ◽  
pp. 253-256 ◽  
Author(s):  
J. Tate Thigpen ◽  
John A. Blessing ◽  
Leo D. Lagasse ◽  
Philip J. DiSaia ◽  
Howard D. Homesley
Keyword(s):  
Endometrial Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Gynecologic Oncology ◽  
Gynecologic Oncology Group ◽  
Second Line ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy

Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: A Gynecologic Oncology Group study

2006 ◽  
Vol 103 (2) ◽  
pp. 523-526 ◽  
Author(s):  
Paula M. Fracasso ◽  
John A. Blessing ◽  
Kelly L. Molpus ◽  
Lisa M. Adler ◽  
Joel I. Sorosky ◽  
...  
Keyword(s):  
Endometrial Carcinoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Gynecologic Oncology ◽  
Gynecologic Oncology Group ◽  
Second Line ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document